You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 7, 2024

PERFLUOROHEXYLOCTANE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for perfluorohexyloctane and what is the scope of freedom to operate?

Perfluorohexyloctane is the generic ingredient in one branded drug marketed by Bausch And Lomb Inc and is included in one NDA. There are six patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Perfluorohexyloctane has one hundred and seven patent family members in sixteen countries.

One supplier is listed for this compound.

Summary for PERFLUOROHEXYLOCTANE
International Patents:107
US Patents:6
Tradenames:1
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 52
Clinical Trials: 5
Patent Applications: 157
What excipients (inactive ingredients) are in PERFLUOROHEXYLOCTANE?PERFLUOROHEXYLOCTANE excipients list
DailyMed Link:PERFLUOROHEXYLOCTANE at DailyMed
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for PERFLUOROHEXYLOCTANE
Generic Entry Date for PERFLUOROHEXYLOCTANE*:
Constraining patent/regulatory exclusivity:
NEW CHEMICAL ENTITY
Dosage:
SOLUTION/DROPS;OPHTHALMIC

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Recent Clinical Trials for PERFLUOROHEXYLOCTANE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Gordon Schanzlin New VisionPhase 4
Bausch & Lomb IncorporatedPhase 3
Novaliq GmbHPhase 3

See all PERFLUOROHEXYLOCTANE clinical trials

US Patents and Regulatory Information for PERFLUOROHEXYLOCTANE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch And Lomb Inc MIEBO perfluorohexyloctane SOLUTION/DROPS;OPHTHALMIC 216675-001 May 18, 2023 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bausch And Lomb Inc MIEBO perfluorohexyloctane SOLUTION/DROPS;OPHTHALMIC 216675-001 May 18, 2023 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bausch And Lomb Inc MIEBO perfluorohexyloctane SOLUTION/DROPS;OPHTHALMIC 216675-001 May 18, 2023 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bausch And Lomb Inc MIEBO perfluorohexyloctane SOLUTION/DROPS;OPHTHALMIC 216675-001 May 18, 2023 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for PERFLUOROHEXYLOCTANE

Country Patent Number Title Estimated Expiration
China 110403923 半氟化化合物和其组合物 (SEMIFLUORINATED COMPOUNDS AND THEIR COMPOSITIONS) ⤷  Sign Up
Poland 3181119 ⤷  Sign Up
Canada 2997744 COMPOSITIONS COMPRENANT DES MELANGES D'ALCANES SEMI-FLUORES (COMPOSITIONS COMPRISING MIXTURES OF SEMIFLUORINATED ALKANES) ⤷  Sign Up
Japan 2019520357 局所投与方法 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.